BeStock  
Stocks › Biotechnology › TVTX

Travere Therapeutic TVTX

US equityMarket cap rank #2128Biotechnology
$47.00 −$1.30 (-2.69%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $47.29 +0.62%
Open$48.09
Prev close$48.30
Day range$46.90 – $49.35
Volume1.33M
Market cap$4.51B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts11
Average target$73.40+56.2% vs. price
  • Buy 91%
  • Hold 9%
Low $62.00Now $47.00Avg $73.40High $86.00

Recent rating changes

The last 20 actions on file set price targets from $62.00 to $89.00, averaging $73.95.

DateFirmRatingTarget
6 Nov 2026 J.P. Morgan BUY $86.00
4 Nov 2026 CCORF BUY $72.00
3 Nov 2026 Cantor Fitzgerald BUY –
3 Nov 2026 Wells Fargo BUY $80.00
3 Nov 2026 BofA Securities BUY $70.00
3 Nov 2026 Wedbush BUY $76.00
3 Nov 2026 Stifel HOLD $62.00
3 Nov 2026 Guggenheim BUY $78.00
3 Nov 2026 H.C. Wainwright BUY $67.00
2 Nov 2026 TD Cowen BUY $75.00
28 Oct 2026 CCORF BUY $70.00
28 Oct 2026 BofA Securities BUY $71.00
26 Oct 2026 H.C. Wainwright BUY $67.00
21 Oct 2026 Piper Sandler BUY $68.00
15 Oct 2026 Wells Fargo BUY $80.00
6 Oct 2026 Guggenheim BUY $89.00
2 Oct 2026 H.C. Wainwright BUY $67.00
23 Sep 2026 BofA Securities BUY $71.00
23 Sep 2026 Guggenheim BUY $89.00
23 Sep 2026 H.C. Wainwright BUY $67.00

Discussion

No comments yet — be the first to weigh in on TVTX.

Sign in to join the discussion.

Scroll to Top